Features of psychoemotional disorders in patients with multiple sclerosis in different clinical and demographic groups
<p>Purpose: to conduct an analysis of psychoemotional disorders in patients with multiple sclerosis, who are not receiving any treatment for these disorders. Material and Methods. A cohort of patients with a reliable diagnosis of multiple sclerosis, according to the criteria of С Poseur, consi...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Saratov State Medical University
2018-03-01
|
Series: | Саратовский научно-медицинский журнал |
Subjects: | |
Online Access: | http://www.ssmj.ru/system/files/2018_01-1_151-153.pdf |
_version_ | 1818441807627812864 |
---|---|
author | Lukina E.V. Chernysheva О.А. Eliseeva V.A. |
author_facet | Lukina E.V. Chernysheva О.А. Eliseeva V.A. |
author_sort | Lukina E.V. |
collection | DOAJ |
description | <p>Purpose: to conduct an analysis of psychoemotional disorders in patients with multiple sclerosis, who are not receiving any treatment for these disorders. Material and Methods. A cohort of patients with a reliable diagnosis of multiple sclerosis, according to the criteria of С Poseur, consisting of 163 people, was selected for the research. A four-dimensional symptomatic questionnaire was used to assess distress, depression, anxiety and somatization (4DSQ) and a self-questionnaire for evaluating the symptoms of fibromyalgia with quantitative measures (WPI, SS, FS). Re-sults. Differences in the average values of the level of distress, depression, anxiety and somatization in patients with multiple sclerosis of different sex, age, with different type of course and duration of the disease are shown. Conclusion. The neuropsychological status of patients depends on the type of course of the disease, the level of distress — from age and sex, the level of somatization —from the age of this category of patients. In the complex treatment of this category of patients it is necessary to use symptomatic treatment in addition to pathogenetic therapy, which has not only neurotrophic and vasoactive effects, but also affects the psychoemotional background of patients.</p> |
first_indexed | 2024-12-14T18:34:07Z |
format | Article |
id | doaj.art-6e047e2b50f24ef4a64a029806abe914 |
institution | Directory Open Access Journal |
issn | 2076-2518 |
language | Russian |
last_indexed | 2024-12-14T18:34:07Z |
publishDate | 2018-03-01 |
publisher | Saratov State Medical University |
record_format | Article |
series | Саратовский научно-медицинский журнал |
spelling | doaj.art-6e047e2b50f24ef4a64a029806abe9142022-12-21T22:51:40ZrusSaratov State Medical UniversityСаратовский научно-медицинский журнал2076-25182018-03-011411511534989Features of psychoemotional disorders in patients with multiple sclerosis in different clinical and demographic groupsLukina E.V.0Chernysheva О.А.1Eliseeva V.A.2Saratov State Medical UniversitySaratov State Medical UniversitySaratov State Medical University<p>Purpose: to conduct an analysis of psychoemotional disorders in patients with multiple sclerosis, who are not receiving any treatment for these disorders. Material and Methods. A cohort of patients with a reliable diagnosis of multiple sclerosis, according to the criteria of С Poseur, consisting of 163 people, was selected for the research. A four-dimensional symptomatic questionnaire was used to assess distress, depression, anxiety and somatization (4DSQ) and a self-questionnaire for evaluating the symptoms of fibromyalgia with quantitative measures (WPI, SS, FS). Re-sults. Differences in the average values of the level of distress, depression, anxiety and somatization in patients with multiple sclerosis of different sex, age, with different type of course and duration of the disease are shown. Conclusion. The neuropsychological status of patients depends on the type of course of the disease, the level of distress — from age and sex, the level of somatization —from the age of this category of patients. In the complex treatment of this category of patients it is necessary to use symptomatic treatment in addition to pathogenetic therapy, which has not only neurotrophic and vasoactive effects, but also affects the psychoemotional background of patients.</p>http://www.ssmj.ru/system/files/2018_01-1_151-153.pdfanxietydepressiondistressmultiple sclerosissomatization |
spellingShingle | Lukina E.V. Chernysheva О.А. Eliseeva V.A. Features of psychoemotional disorders in patients with multiple sclerosis in different clinical and demographic groups Саратовский научно-медицинский журнал anxiety depression distress multiple sclerosis somatization |
title | Features of psychoemotional disorders in patients with multiple sclerosis in different clinical and demographic groups |
title_full | Features of psychoemotional disorders in patients with multiple sclerosis in different clinical and demographic groups |
title_fullStr | Features of psychoemotional disorders in patients with multiple sclerosis in different clinical and demographic groups |
title_full_unstemmed | Features of psychoemotional disorders in patients with multiple sclerosis in different clinical and demographic groups |
title_short | Features of psychoemotional disorders in patients with multiple sclerosis in different clinical and demographic groups |
title_sort | features of psychoemotional disorders in patients with multiple sclerosis in different clinical and demographic groups |
topic | anxiety depression distress multiple sclerosis somatization |
url | http://www.ssmj.ru/system/files/2018_01-1_151-153.pdf |
work_keys_str_mv | AT lukinaev featuresofpsychoemotionaldisordersinpatientswithmultiplesclerosisindifferentclinicalanddemographicgroups AT chernyshevaoa featuresofpsychoemotionaldisordersinpatientswithmultiplesclerosisindifferentclinicalanddemographicgroups AT eliseevava featuresofpsychoemotionaldisordersinpatientswithmultiplesclerosisindifferentclinicalanddemographicgroups |